This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.
Full 2023 Agenda
07.30 - 08.00 AM
Registration and Morning Coffee
08.00 - 08.15 AM
Opening Remarks From The Organizer and Chair
08.15 - 08.30 AM
Ice-Breaking and Networking Activity
08.30 - 09.10 AM Presentation
What have we learned that tells us what the future may hold for DTx?
Elcie Chan
Making a successful business out of Digital
therapeutics (DTx) is challenging... to say the
least. Partly because the field is complex, with DTx
encompassing a variety of products that can mean
different things to different people. Partly because
health authorities and providers around the world
are evolving how they are making decisions around
access and adoption of these products. Over the
last 5 years we’ve seen a variety of successes and
failures. What have we learned already? What can
we expect for the future? This presentation aims
to provide a perspective on what our industry
may need to prepare for to develop DTx and a
commercial strategy that will stand up to the rigors
of value assessments and support a sustainable and
profitable business for the future.
Key points:
- What is encompassed under the umbrella of DTx and how does this impact determination of value?
- How have payers in Europe evolved their approach to evaluating DTx for pricing and reimbursement?
- What has and has not worked to drive healthcare provider adoption and patient uptake?
Elcie Chan
EU Commercial Director – Digital Health
Otsuka
09.10 - 09.50 AM Presentation
Improving the Treatment of Migraine Patients With Digital Technology
Beth Wolff
Migraine patients in Denmark can spend 15-20
years suffering misdiagnosis and under-treatment
due to low awareness of migraines amongst GPs.
This prevents them from being referred to specialist
care and increases the burden of the disease for the
patients. Lundbeck aims to create a unique cohort of
RWE combining PROs and usage data from a digital
health solution with Danish public registry data to
better understand the patient journey, QoL, and
burden of the disease. The outputs of these data
will be used to better educate the GPs on migraine
sufferers and increase the quality of care.
Key points:
- Unique partnership between Lundbeck (a
pharmaceutical company specializing in brain
diseases), a digital health provider, and the national
center for research on migraines - Combing data collected from digital solutions with
public registry data - Redefining Phase IV studies with digital
technologies
Beth Wolff
Director Digital Health Solutions, Global Corporate
Lundbeck
09.50 - 10.20 AM
Coffee-Break
10.20 - 11.00 AM
Building the Future of Pharma: Digital Health at the Forefront
Marcus Bates
Join us for a journey into the universe of digital health and connected devices. The presentation “Building the Future of Pharma: Digital Health at the Forefront” is designed to ignite curiosity and unveil a new era of healthcare solutions.
What to Expect:
- Discover Trailblazing Innovations: Get a first-hand look at Aptar Digital Health product portfolio, designed to meet the evolving needs of patients, healthcare providers and life science companies. From connected drug delivery devices to Software as Medical Devices (SaMD), we're introducing innovative solutions that redefine healthcare possibilities.
- Value of Digital Health: Witness the tangible impact of digital health solutions as we share case studies from collaborations. Learn how digital health is enhancing the patient experience.
- The Future of Pharma Collaboration: Be at the forefront of a collaborative vision for the future. Explore how ADH co-creates tailored solutions, addressing specific challenges and forging a path to enhanced patient care and industry growth.
Marcus Bates
VP Business Development
Aptar Digital Health
11.00 - 11.30 AM
Prova Health Presentation
Dr. Saira Ghafur
TBA
Dr. Saira Ghafur
Co-Founder
Prova Health
11.30 - 12.00 PM
Roundtable Discussion
All delegates will have 30 minutes to discuss
trending topics in the digital health sector.
12.00 - 13.00 PM
Lunch
13.00 - 13.30 PM
Roundtable Discussion
All delegates will have 30 minutes to discuss
trending topics in the digital health sector.
13.30 - 14.10 PM Presentation
Scaling Digital Innovation in Pharma: When Adulthood Hits
Yoram Griguer
When transitioning from a solution factory to
managing a portfolio lifecycle, many challenges
arise.
We will discuss the significance of systematically
gaining insights, anticipating the industry bound
constraints and formalizing the value our
solutions bring to effectively navigate this growth
phase within the pharmaceutical industry.
Yoram Griguer
Head of Digital Health Solutions Engineering Biogen Digital Health (BDH)
&
Emmanuel Dru
Head of Discovery & Innovation Lab
Biogen Digital Health (BDH)
14.10 - 14.50 PM Presentation
Healthcare Data, the Value of Digital Health Data for Empowering Consumers to Become Proactive Rather than Reactive
Dr. Sachin Shah
Patient-centred healthcare is paramount in shifting
healthcare from reactive to proactive. What is equally
important is patient-centred research to ensure
outcomes reflect the true disease state in a way that
matters to patients. Digital health technologies are
a key tool to help drive patient centricity, to not only
ensure more valuable meaningful outcomes, but also
increase the chance of success when running clinical
research.
Dr. Sachin Shah
Global Medical Partner, Digital Health & Devices
Haleon
14.50 - 15.20 PM
Coffee-Break
15.20 - 16.00 PM Presentation
Digital Strategy & it's translation in a Digital Unprecedented Launch
Gemma Malla Salomó
Angelini Pharma's digital strategy and how we see its impact on P&L.
Concretely, how did we apply it to a launch and how was it digitally unprecedented versus what we could have done differently 5 years ago.
- Digital Strategy: Culture, Efficency, Omnichanel & Beyond the pill
- Impact on P&L of Digital Strategy
- From Strategy to Execution
- How did we apply it to a Digital Unprecedented Launch
Gemma Malla Salomó
Head of Digital Medicines Iberia
Angelini Pharma
16.00 - 16.40 PM
(Clinical) Data is Food for Healthcare AI
Pascal Bouquet
In this engaging presentation, titled “(Clinical) Data is
Food for Healthcare AI,” we will delve into the crucial
role of data in training healthcare AI algorithms.
Exploring the benefits and limitations of data types
like EHR and Real-World Data, we will highlight
the immense value of data from clinical trials.
Additionally, the session will feature the author’s
first-hand experience in successfully implementing
a groundbreaking solution to democratize access to
legacy clinical trial data, providing valuable insights
for the audience to leverage in their own endeavors.
16.40 - 17.10 PM
Overview & Insights for the Public Digital Health Market
Nico Bacharidis
Understanding the Public Digital Health Market
and accelerating growth & market share through
tender visibility & excellence.
Nico Bacharidis
Chief Commercial Officer
Cube RM
17.10 - 17.40 PM
Coffee-Break
17.40 - 18.20 PM Presentation
Digital Health is a Journey, not a Destination: Lessons Learned in Steppingstones Towards a Future of Possibilities
Sofie Roorda
Building Digital Health solutions, in particular,
Software as Medical Devices (SaMD) solutions
is not a simple task. It’s not just an app. It’s not
finished when it’s done. And in the case of chronic
diseases, it’s not a product anyone wished they had
to use. Digital Health is a journey: It’s not just about
implementing technology but creating a culture
of innovation that fosters continuous learning,
experimentation, and improvement. It’s about
embedding Digital Health early in our development
and building upon it once in the hands of users.
It’s about collaborating, partnering, and building
an ecosystem of value. It’s about building a solid
foundation in steps toward a future where Digital
Health is a key enabler of better health outcomes.
This session will explore the lessons learned
navigating in big pharma, lessons learned from
building solutions, and how the steps taken are part
of steps towards an emerging future of a changing
healthcare ecosystem.
Key takeaways:
• Understanding the importance of embracing the
journey and lessons if you don’t
• Examples of the steps we’ve made so far, and how
we believe they enable a future of improved health
outcomes and an emerging health system
Sofie Roorda
Global Associate Strategy Director Digital Health
Novo Nordisk
18.20 - 18.50 PM
Panel Discussion - The Value of Data - Empowering Consumers to Become Proactive Rather than Reactive
Topic: The Value of Data - Empowering Consumers to Become Proactive Rather than Reactive
Panelists:
Yoram Griguer
Head of Digital Health Solutions Engineering,
Biogen Digital Health
Beth Wolf
Director Digital Health Solutions, Global
Lundbeck
Maria João Jacinto
Executive Director
Patient Innovation
Sofie Roorda
Global Associate Strategy Director Digital Health
Novo Nordisk
Dr. Sachin Shah
Global Medical Partner, Digital Health & Devices
Haleon
Moderator
Sara Rico
Customer Success Account Manager
Microsoft
7:45 - 8:00 AM
Registration and Morning Coffee
8:00 - 8:05 AM
Opening Remarks From The Chair
8.05 - 8.45 AM Presentation
The laboratory journey to become a decision engine: a roadmap for diagnostics transformation
Florian Lange
Laboratories and diagnostic departments are
sitting over a massive amount of data they are not
leveraging. Data is the new black gold of healthcare
organizations and by extracting insights from it,
laboratories could become decision engines, driving
action across healthcare. This presentation will
respond to 3 fundamental questions:
1) Where are we? Having a look at the biggest trends
and challenges in healthcare provides some light on
the status of diagnostics.
2) Where do we want to be? Reviewing the
opportunities for digital health, the healthcare of the
future, and providing some inspiration about how
success looks like.
3) What do we need? Explaining what Abbott and
its branch Digital Health Solutions, are doing in this
regard. This will include information about how DHS
could help in the Dx Cycle and how to set a roadmap
for Labs and Diagnostic organizations.
Florian Lange
Director Digital Health Solutions EMEA
Abbott
8.45 - 9.05 AM Presentation
Metaverse in Pharma Industry - What's Next?
Stefania Alvino
- What are the new innovative trends?
- Is the metaverse ready for the market?
Stefania Alvino
Head of Digital Innovation
Daiichi Sankyo
9:05 - 9:30
Roundtable Discussion
Suggested topics:
- Examine strategies for using digital tools to improve patient engagement and medication adherence
- Consider how different regions and countries are adopting digital health solutions in pharmaceuticals and the implications for global healthcare.
- Consider how digital health initiatives can address healthcare disparities and ensure equal access to innovative pharmaceutical treatments.
9:30 - 10:00 AM
Coffee Break
10.00 - 10.40 AM Presentation
The Vision of Amazon Web Services - Bring Innovation at the Service of Healthcare
Filipe Quirino
Healthcare pressures of driving higher quality at a lower cost have never been more predominant. Financial pressures continue to rise worldwide, more than half of clinicians suffer burnout, there is an increased need for personalized care with a population that lives longer but also with higher chronic conditions, health equity continues to be a challenge and millions of data points are managed every day to try to make inform decisions.
AWS mission is to enable access and delivery of person-centered healthcare, driving improved outcomes at a lower cost by accelerating the digitization and utilization of healthcare & life sciences data. During this session, you will hear how one of the most innovative companies in the world is applying its customer-obsessed leadership principle to transform healthcare and challenge the status quo.
Learn innovative strategies on how to:
- Drive innovation to enhance quality and reduce costs.
- Serve diverse, high-need populations with clinical and social service needs
- Make data actionable using AI/ML and advanced analytics on disparate data
- Enable a journey to personalized care
Filipe Quirino
Senior Territory Manager - Portugal
Amazon Web Services
10.40 - 11.20 AM Presentation
Unlocking the Untapped Potential of Data Generated by Digital Health
Jonas Abdel Khalik
Digital Health is progressing rapidly. Today, many
patients and citizens are using or subjected to one or
more digital devices to track their health regularly,
as the use of technology, including wearables, in
healthcare is expanding rapidly. However, the use of
the data generated by these digital health products
remains fairly limited, and could hold a lot of
untapped potential that is yet to be fully explored.
In this session, we will look at:
- How the data capturing landscape around a patient
has changed over the past decade
- Current status and barriers in leveraging data
generated by digital health products
- Efforts and actions needed to unlock the potential
of this data
Jonas Abdel-Khalik
Digital Health Lead Nordics
Takeda
11:20 - 12:00 AM
StartUp Pitch Session
During the pitch session, 2 startups will be
promoting their innovative solutions:
- BlueSkeye AI
Presentation: Using Face and Voice Scanning AI for Better Health, Improved Wellbeing and Enhanced Clinical Trials
Dr Sarah Wright
Director of Business Development and Customer Success
- Avegen Health
Presentation: Unleashing the Potential: How Pharma Can Harness the Digital Health Platform Approach
Description: Join us to dive into the dynamic world of digital health platforms and uncover their strategic benefits for enhancing patient care and amplifying the potential of existing pharmaceutical products. Gain insights into how platforms can help pharma drive more value for all healthcare partners.
Jamie Campbell
Director of Commercial Partnerships
12:00 - 13:00 PM
Lunch
13:00 - 13:40 PM
Software Defined Medical Systems - Tesla Model for Medical Devices
Ozgur Butun
Philips is innovating from stand alone medical devices
to “software defined medical systems”. To realize this
we have identified 4 major capability areas;
1. Over the air upgrades & updates
2. Lightweight Software Stack
3. Subscription based Business Models
4.Modular Hardware.
As an Innovation capability leader, I am partnering with businesses, following the heartbeat of new product introductions and working very closely with key customers.
A software-defined medical system is the first key
step to enable Data/Ai, Software as Medicine and
Cyber Secure. A medical system can only be secure
and deliver good quality data for ML applications;
if it’s connected & frequently updated, has a non-monolithic software stack, quickly and easily
maintained and offers solutions when the customer
needs per duration they need it.
Bullet Points:
Software Defined Medical Systems:
- Over the air update & upgrade -able medical devices
- Lightweight stacked medical software
- Subscription based customer solutions
- Modular Medical Hardware
Ozgur Butun
Director - Customer First Digital Innovation
Philips
13.40 - 14.20 PM Presentation
Carers' role in Digtial Health
Davie Chen
Carers have an important role to play in the Healthcare ecosystem, however, they are always being neglected especially in the Primary care setting. This presentation is to discuss the strategy and operations of a newly developed Digital Platform - Carerhood (funded by GSK). It aims to support the Carers by providing not only updated disease information for better care of their loved ones but also self-care content which is crucial for Carers to support their sustainable and balanced life.
Key points:
- Share the concept of carerhood
- How do we bring the concept to life?
- What different stakeholders in the community shall support these initiatives?
- Longer plan to make it sustainable for the digital health agenda
Davie Chen
Head of Digital Platforms and Data Strategy
GSK
14:20 - 15:00 PM
How to Successfully Launch a Digital Health solution within a Pharmaceutical Company?
Marta Solé
Accord Healthcare has developed a set of digital
health solutions: Unify Health is a mobile app for
people living with cancer and Oncodemia is an online
cancer training program aimed at the community
pharmacies, both solutions interact together so that
through Unify Health patients can connect with a
local pharmacist who can talk about cancer care
and other matters that living with cancer raises, like
symptoms or side effects management. It has been
an interesting and enriching journey, and the speech
will cover everything from ideation all the way to
commercialization in several European markets.
- Strategy and commercial fit
- Patient centricity and how to define the user
pathway
- The importance of partnerships and endorsements
- Navigating compliance and data regulations
- Localisation throughout Europe
- Growth and marketing
Marta Solé
Associate Director Digital Health EMENA
Accord Health
15:00 - 15:40 PM
Digital Ecosystem as a Enabler of New Business Models and Ways in Interdisciplinary Collaboration to Cover the Evolving Needs of Patients, Healthcare Professionals and Stakeholders in Oncology
Andreas Kuptz
TBA
Andreas Kuptz
Senior Strategy Consultant, Digital Transformation
& IT Strategy
Bayer
15:40 - 16:00 PM
Closing Coffee Break
16:00 - 17:45 PM
Bus/Boat Sightseeing - Hippo Trip
16:15h Pick Up - Praça dos Restauradores (350m walk from the hotel)
17:45h Drop OFF - Doca de Santo Amaro
Transfer - Hotel Mundial